Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucagon-Like Peptide-1 Receptor Agonists and Outcomes After Intracerebral Hemorrhage in Patients With Type 2 Diabetes: A Propensity-Matched Cohort Study.

Neurosurgery·2026
Same author

Temporal patterns of facial nerve palsy after microsurgical resection of vestibular schwannoma: immediate vs. delayed onset, management, and outcomes.

Neurosurgical review·2026
Same author

Combination of Albumin and Cilostazol Improves Outcomes in a Rodent Model of Aneurysmal Subarachnoid Hemorrhage.

Neurocritical care·2026
Same author

Electroconvulsive Therapy in a Patient With Down Syndrome Regression Disorder and Inspire Device: A Case Report.

The journal of ECT·2026
Same author

Functional Outcomes After Endovascular Versus Open Surgical Approach for Treatment of Spinal Dural Arteriovenous Fistula.

Neurosurgery·2026
Same author

Headache resolution following middle meningeal artery embolization in chronic subdural hematoma patients.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Related Experiment Video

Updated: May 25, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

Copeptin in aneurysmal subarachnoid hemorrhage.

Rafael J Tamargo1

  • 1Department of Neurosurgery, Johns Hopkins University School of Medicine, The Johns Hopkins Hospital, 600 N, Wolfe Street, Meyer 8-181, Baltimore, MD 21287, USA. rtamarg@jhmi.edu

Critical Care (London, England)
|January 13, 2012
PubMed
Summary

Elevated copeptin levels in patients with aneurysmal subarachnoid hemorrhage (SAH) indicate a higher risk of vasospasm and poor outcomes. Further research into copeptin

Area of Science:

  • Neurology
  • Biochemistry

Background:

  • Copeptin is a stable biomarker derived from the vasopressin precursor.
  • Aneurysmal subarachnoid hemorrhage (SAH) is a critical neurological condition with significant morbidity and mortality.

Purpose of the Study:

  • To investigate the correlation between serum copeptin levels and clinical outcomes in patients with aneurysmal SAH.
  • To explore the prognostic value of copeptin in SAH management.

Main Methods:

  • Serum copeptin levels were measured in patients diagnosed with aneurysmal SAH.
  • Correlation analysis was performed between copeptin levels and outcomes such as vasospasm, mortality, and functional status.

Main Results:

  • Elevated serum copeptin levels were significantly associated with the presence of vasospasm.

More Related Videos

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
10:34

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
09:14

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model

Published on: June 18, 2021

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage
10:34

Double Direct Injection of Blood into the Cisterna Magna as a Model of Subarachnoid Hemorrhage

Published on: August 30, 2020

  • Higher copeptin levels correlated with increased inpatient mortality, 1-year mortality, and poor functional outcomes at 1 year post-SAH.
  • Conclusions:

    • Serum copeptin is a promising biomarker for predicting outcomes in aneurysmal SAH.
    • Further investigation into the clinical utility of copeptin in SAH patient management is warranted.